UK markets close in 4 hours 36 minutes

OrbusNeich Medical Group Holdings Limited (Q8T.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.5250+0.0470 (+9.83%)
As of 08:46AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 413.41M
Enterprise value 184.64M
Trailing P/E 9.59
Forward P/E 12.95
PEG ratio (5-yr expected) 0.86
Price/sales (ttm)2.81
Price/book (mrq)1.17
Enterprise value/revenue 1.30
Enterprise value/EBITDA 3.71

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-62.39%
S&P500 52-week change 327.84%
52-week high 31.3670
52-week low 30.3260
50-day moving average 30.4117
200-day moving average 30.7085

Share statistics

Avg vol (3-month) 330
Avg vol (10-day) 31
Shares outstanding 5827.97M
Implied shares outstanding 6864.88M
Float 8235.91M
% held by insiders 163.03%
% held by institutions 112.34%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.01
Forward annual dividend yield 42.46%
Trailing annual dividend rate 30.01
Trailing annual dividend yield 32.72%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 411 Jun 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 29.29%
Operating margin (ttm)21.21%

Management effectiveness

Return on assets (ttm)6.46%
Return on equity (ttm)13.03%

Income statement

Revenue (ttm)153.86M
Revenue per share (ttm)0.19
Quarterly revenue growth (yoy)6.60%
Gross profit (ttm)N/A
EBITDA 41.3M
Net income avi to common (ttm)45.07M
Diluted EPS (ttm)0.0500
Quarterly earnings growth (yoy)90.30%

Balance sheet

Total cash (mrq)256.21M
Total cash per share (mrq)0.31
Total debt (mrq)7.46M
Total debt/equity (mrq)2.02%
Current ratio (mrq)9.77
Book value per share (mrq)0.44

Cash flow statement

Operating cash flow (ttm)23.03M
Levered free cash flow (ttm)5.32M